A Microdose Trial Investigating Binding of [68Ga]Ga-DOTA-CYS-ATH001 in Healthy Subjects and Different Patient Groups.

Recruiting

Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.

Trial locations(3 sites)

Sweden

CTC Karolinska, Stockholm

CTC Akademiska Uppsala University Hospital, Entrance 85, 2nd level, Uppsala

Section of Gastroenterology/Hepatology, Uppsala University Hospital, Uppsala